HK1005871A1 - Pyrimidine nucleoside derivative - Google Patents
Pyrimidine nucleoside derivativeInfo
- Publication number
- HK1005871A1 HK1005871A1 HK98104955A HK98104955A HK1005871A1 HK 1005871 A1 HK1005871 A1 HK 1005871A1 HK 98104955 A HK98104955 A HK 98104955A HK 98104955 A HK98104955 A HK 98104955A HK 1005871 A1 HK1005871 A1 HK 1005871A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- pyrimidine nucleoside
- nucleoside derivative
- hydroxy
- hydrogen
- represent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15668890 | 1990-06-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1005871A1 true HK1005871A1 (en) | 1999-01-29 |
Family
ID=15633157
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK98104955A HK1005871A1 (en) | 1990-06-15 | 1998-06-05 | Pyrimidine nucleoside derivative |
Country Status (13)
Country | Link |
---|---|
US (2) | US5616567A (xx) |
EP (1) | EP0535231B1 (xx) |
JP (1) | JP2559917B2 (xx) |
KR (1) | KR970011306B1 (xx) |
AT (1) | ATE122041T1 (xx) |
CA (1) | CA2085345C (xx) |
DE (1) | DE69109482T2 (xx) |
DK (1) | DK0535231T3 (xx) |
ES (1) | ES2074719T3 (xx) |
HK (1) | HK1005871A1 (xx) |
HU (1) | HU218924B (xx) |
RU (1) | RU2116306C1 (xx) |
WO (1) | WO1991019713A1 (xx) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI105556B (fi) * | 1991-09-30 | 2000-09-15 | Sankyo Co | Menetelmä lääkeaineina käyttökelpoisten pyrimidiiniukleosidijohdannaisten valmistamiseksi, joilla on kasvaimen vastaista vaikutusta |
KR20030036189A (ko) * | 2000-05-26 | 2003-05-09 | 이데닉스(케이만)리미티드 | 플라비바이러스 및 페스티바이러스의 치료방법 및 조성물 |
MY142304A (en) * | 2005-01-31 | 2010-11-15 | Taiho Pharmaceutical Co Ltd | Novel pyrimidine nucleoside compound or salt thereof |
GB0523041D0 (en) * | 2005-11-11 | 2005-12-21 | Cyclacel Ltd | Combination |
WO2008010571A1 (fr) | 2006-07-21 | 2008-01-24 | Taiho Pharmaceutical Co., Ltd. | Composé nucléosidique de 2'cyanopyrimidine |
GB0625283D0 (en) | 2006-12-19 | 2007-01-24 | Cyclacel Ltd | Combination |
RU2488591C2 (ru) * | 2007-09-26 | 2013-07-27 | Маунт Синай Скул Оф Медсин | Аналоги азацитидина и их применение |
US8124593B2 (en) | 2007-11-05 | 2012-02-28 | Cyclacel Limited | Methods of treatment using sapacitabine |
US7863255B2 (en) * | 2008-04-29 | 2011-01-04 | Taiho Pharmaceutical Co., Ltd. | Methods of administering antitumor agent comprising deoxycytidine derivative |
GB0808359D0 (en) * | 2008-05-08 | 2008-06-18 | Cyclacel Ltd | Process |
GB0808357D0 (en) * | 2008-05-08 | 2008-06-18 | Cyclacel Ltd | Process |
CA2725295C (en) | 2008-06-09 | 2016-11-08 | Cyclacel Limited | Combination of sapacitabine (cndac) and dna methyltransferase inhibitors such as decitabine and procaine |
DK2431376T4 (da) * | 2009-05-15 | 2024-02-26 | Delta Fly Pharma Inc | Ny stabilt krystal af 1-(2'-cyano-2'-deoxy-ß-D-arabinofuranosyl)cytosinmonohydrochlorid |
EP2696878B1 (en) | 2011-04-14 | 2019-07-10 | Cyclacel Limited | Dosage regimen for sapacitabine and decitabine in combination for treating acute myeloid leukemia |
CN104114568B (zh) | 2011-12-22 | 2017-09-01 | 艾丽奥斯生物制药有限公司 | 取代的核苷、核苷酸及其类似物 |
USRE48171E1 (en) | 2012-03-21 | 2020-08-25 | Janssen Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
US9441007B2 (en) | 2012-03-21 | 2016-09-13 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
JP6286421B2 (ja) | 2012-05-15 | 2018-02-28 | サイクラセル リミテッド | サパシタビン及びセリシクリブの投与レジメン |
WO2019081951A1 (en) | 2017-10-27 | 2019-05-02 | Cyclacel Limited | DOSAGE REGIME |
US11957701B2 (en) | 2020-07-17 | 2024-04-16 | Delta-Fly Pharma, Inc. | Therapy and new therapeutic agent for blood cancer |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2007094A6 (es) * | 1987-07-29 | 1989-06-01 | Consejo Superior Investigacion | Procedimiento para la preparacion de 3 -c- ciano-2,3 -didesoxinucleosido. |
-
1991
- 1991-06-11 JP JP3138859A patent/JP2559917B2/ja not_active Expired - Lifetime
- 1991-06-13 HU HU9203967A patent/HU218924B/hu unknown
- 1991-06-13 KR KR1019920703246A patent/KR970011306B1/ko not_active IP Right Cessation
- 1991-06-13 CA CA002085345A patent/CA2085345C/en not_active Expired - Lifetime
- 1991-06-13 DE DE69109482T patent/DE69109482T2/de not_active Expired - Lifetime
- 1991-06-13 AT AT91911192T patent/ATE122041T1/de not_active IP Right Cessation
- 1991-06-13 EP EP91911192A patent/EP0535231B1/en not_active Expired - Lifetime
- 1991-06-13 RU RU92016591/04A patent/RU2116306C1/ru active
- 1991-06-13 WO PCT/JP1991/000797 patent/WO1991019713A1/ja active IP Right Grant
- 1991-06-13 ES ES91911192T patent/ES2074719T3/es not_active Expired - Lifetime
- 1991-06-13 DK DK91911192.2T patent/DK0535231T3/da active
-
1994
- 1994-09-07 US US08/301,720 patent/US5616567A/en not_active Expired - Lifetime
-
1995
- 1995-06-01 US US08/457,510 patent/US5654420A/en not_active Expired - Lifetime
-
1998
- 1998-06-05 HK HK98104955A patent/HK1005871A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR970011306B1 (ko) | 1997-07-09 |
EP0535231A4 (en) | 1993-06-30 |
CA2085345C (en) | 2001-08-07 |
CA2085345A1 (en) | 1991-12-16 |
KR930700485A (ko) | 1993-03-15 |
JPH04235182A (ja) | 1992-08-24 |
HU218924B (hu) | 2000-12-28 |
ES2074719T3 (es) | 1995-09-16 |
JP2559917B2 (ja) | 1996-12-04 |
DE69109482T2 (de) | 1996-02-15 |
US5616567A (en) | 1997-04-01 |
RU2116306C1 (ru) | 1998-07-27 |
DK0535231T3 (da) | 1995-08-21 |
HUT62582A (en) | 1993-05-28 |
US5654420A (en) | 1997-08-05 |
DE69109482D1 (en) | 1995-06-08 |
HU9203967D0 (en) | 1993-03-29 |
EP0535231A1 (en) | 1993-04-07 |
ATE122041T1 (de) | 1995-05-15 |
WO1991019713A1 (en) | 1991-12-26 |
EP0535231B1 (en) | 1995-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69109482D1 (en) | Pyrimidinnucleosidderivat. | |
AU651442B2 (en) | Aminoguanidine derivatives and their use as pharmaceuticals | |
ATE416186T1 (de) | Phenylethylenamin-derivate | |
SG44794A1 (en) | Novel peptide derivatives | |
DE3851179D1 (de) | Oxetanocin. | |
IL99399A0 (en) | 1-methylcarbapenem derivatives and their preparation | |
GEP19970781B (en) | Uracil derivatives | |
ES2169220T3 (es) | Derivados de vitamina d3 con sustituyentes en la posicion 2. | |
DE69001111D1 (de) | Antikrebs-zusammensetzung. | |
FI940011A (fi) | Mono- ja bis-alkyyliaminoantrasykliinit | |
DK0424899T3 (da) | Hidtil ukendte anthracyclinglycosidderivater og fremgangsmåde til fremstilling deraf | |
DE69303847D1 (de) | Indolderivate | |
ES8402285A1 (es) | Un procedimiento para la preparacion de nuevos derivados de 1-bencil-4-(4-(2-pirimidinilamino)bencil)-2,3-dioxopiperazina o sus sales. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PE | Patent expired |
Effective date: 20110612 |